Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19758
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMyers, Kenneth A-
dc.contributor.authorDavey, Margot J-
dc.contributor.authorChing, Michael-
dc.contributor.authorEllis, Colin-
dc.contributor.authorGrinton, Bronwyn E-
dc.contributor.authorRoten, Annie-
dc.contributor.authorLightfoot, Paul A-
dc.contributor.authorScheffer, Ingrid E-
dc.date2018-10-15-
dc.date.accessioned2018-11-04T23:50:37Z-
dc.date.available2018-11-04T23:50:37Z-
dc.date.issued2018-10-15-
dc.identifier.citationJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2018; 14(10): 1697-1704-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19758-
dc.description.abstractDravet syndrome is a severe developmental and epileptic encephalopathy, in which 75% of patients have sleep disturbance. Melatonin is often used for sleep problems in childhood; however, there is no quality evidence supporting its use in Dravet syndrome. We hypothesized that melatonin would increase total sleep and quality of life for patients with Dravet syndrome. A double-blind crossover randomized placebo-controlled trial was conducted, comparing 6 mg regular-release melatonin to placebo for patients with Dravet syndrome and sleep disturbance. The primary outcome measure was total sleep measured by actigraphy, with secondary outcomes including wakefulness after sleep onset (WASO), Sleep Disturbance Scale in Children and Quality of Life in Children with Epilepsy 55 questionnaires, caregiver reports of clinical change, seizure diary and serum antiepileptic drug levels. We also compared actigraphy data of patients with Dravet syndrome to an age-matched healthy control group. A total of 13 patients completed the study. There was no difference in total sleep or WASO between melatonin and placebo. However, of the 11 patients for whom caregivers reported a clear clinical difference between treatments (blinded), 8 reported improvement on melatonin (P < .05). Interestingly, when compared to patients in the control group, patients with Dravet syndrome had significantly increased total sleep (P = .002). Melatonin did not increase total sleep; however, blinded caregiver reports indicate treatment with melatonin provided considerable clinical benefit for some patients with Dravet syndrome and sleep disturbance. Registry: Australian Government Department of Health, Therapeutic Goods Administration under the Clinical Trials Notification Scheme (protocol number 2241).-
dc.language.isoeng-
dc.subjectDravet syndrome-
dc.subjectactigraphy-
dc.subjectmelatonin-
dc.subjectscn1a-
dc.subjectsleep-
dc.titleRandomized Controlled Trial of Melatonin for Sleep Disturbance in Dravet Syndrome: The DREAMS Study.-
dc.typeJournal Article-
dc.identifier.journaltitleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine-
dc.identifier.affiliationMelbourne Children's Sleep Centre, Monash Children's Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationPharmacy Department, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationEpilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Paediatrics, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Neurology, Royal Children's Hospital, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartments of Pediatrics and Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canadaen
dc.identifier.doi10.5664/jcsm.7376-
dc.identifier.orcid0000-0001-7831-4593en
dc.identifier.orcid0000-0002-2311-2174en
dc.identifier.pubmedid30353809-
dc.type.austinJournal Article-
local.name.researcherChing, Michael
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptPharmacy-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

48
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.